澳大利亚良性前列腺梗阻手术再修订率
该研究利用澳大利亚Medicare纵向数据,评估2005至2010年间因良性前列腺增生接受经尿道前列腺电切术(TURP)、经尿道前列腺切开术(TUIP)或选择性激光前列腺汽化术(PVP)的患者在5年随访时的再修订手术率。结果显示TURP、TUIP和PVP的再修订率分别为10.3%、13.6%和11.6%,差异无统计学意义(P=0.12),提示TURP与PVP在5年随访时耐久性相似。
要点
- 2005至2010年间TURP占90%(5579例),TUIP占6%(345例),PVP占4%(258例)。
- 5年再修订率:TURP 10.3%(573/5579)、TUIP 13.6%(47/345)、PVP 11.6%(30/258),差异无统计学意义(P=0.12)。
- TURP是再修订手术中最常见的初次术式(75%)。
核心结论
- 本研究提示TURP与PVP在5年随访时具有相似的耐久性。
研究设计与样本
- 利用澳大利亚Medicare Benefits Schedule(MBS)纵向数据的观察性研究,纳入2005至2010年间接受初次TURP(项目号37203)、TUIP(37207)或PVP(36854)的40岁以上患者,随访至2015年评估5年再修订手术需求。
主要发现
- 2005至2010年间初次手术分布为TURP 5579例(90%)、TUIP 345例(6%)、PVP 258例(4%)。
- 5年随访时再修订手术率分别为TURP 10.3%(573/5579)、TUIP 13.6%(47/345)、PVP 11.6%(30/258),差异无统计学意义(P=0.12)。
- TURP是需再修订手术患者中最常见的初次术式(75%)。
- 各年份间需再修订手术的男性数量无显著变化(P=0.59)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the rate of revision surgery following commonly performed procedures for benign prostatic hyperplasia (BPH) is hyperplasia of both glandular and stromal components of prostate especially in periurethral transitional gland, using real-world data from Medicare Australia. METHODS: Prospection is a Healthcare Data Analytics firm that has negotiated access with the Medicare Benefits Schedule (MBS) to provide longitudinal data on the use of specific procedural item codes. We identified patients over the age of 40 years who had undergone primary transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP) or photoselective vaporization of the prostate (PVP) between 2005 and 2010 using MBS item numbers 37203, 37207 and 36854, respectively. Using longitudinal MBS data, primary outcomes included need for revision surgery at 5-years follow-up (2015). The release of these data was approved by Medicare Australia upon application. Data analysis was conducted using chi-squared tests and statistical significance was defined at P < 0.05. RESULTS: The distribution of primary surgical procedures performed between 2005 and 2010 was: TURP 5579 (90%), TUIP 345 (6%) and PVP 258 (4%). TURP was also the most prevalent procedure for treatment of lower urinary tract symptoms in men with BPH requiring revision surgery (75%). At 5-year follow-up the rate of revision surgery for TURP (573/5579), TUIP (47/345) and PVP (30/258) was 10.3%, 13.6% and 11.6%, respectively. The difference was not statistically significant (P = 0.12). There was no significant change (P = 0.59) observed over the years in number of men requiring revision surgery. CONCLUSION: This study indicates that TURP and PVP have a similar durability after 5 years of follow-up.
引用
- Jain A, Nassour AJ, Khannani H, et al. Australian surgical revision rate for benign prostatic obstruction. BJU Int. 2023. PMID: 37346012. doi:10.1111/bju.16031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。